174 related articles for article (PubMed ID: 26816662)
21. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
22. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism in Apolipoprotein C3 (APOC3) and Fatty Acid-Binding Proteins (FABP2) Genes in Nondiabetic Dyslipidemic Patients: A Tertiary Care Hospital-Based Pilot Study.
Chowdhary R; Masarkar N; Khadanga S
J Lab Physicians; 2022 Jun; 14(2):119-124. PubMed ID: 35982873
[No Abstract] [Full Text] [Related]
24. The associations between endothelial lipase 584C/T polymorphism and HDL-C level and coronary heart disease susceptibility: a meta-analysis.
Cai G; Huang Z; Zhang B; Weng W; Shi G
Lipids Health Dis; 2014 May; 13():85. PubMed ID: 24886585
[TBL] [Abstract][Full Text] [Related]
25. Associations between nine candidate genetic polymorphisms with coronary heart disease : A meta-analysis.
Li Q; Du Q
Herz; 2020 Dec; 45(Suppl 1):15-28. PubMed ID: 31041492
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of -174G>C and -572G>C in the interleukin 6 (IL-6) gene and coronary heart disease risk: a meta-analysis of 27 research studies.
Zheng GH; Chen HY; Xiong SQ
PLoS One; 2012; 7(4):e34839. PubMed ID: 22509361
[TBL] [Abstract][Full Text] [Related]
27. Association between GNB3 c.825C > T polymorphism and the risk of overweight and obesity: A meta-analysis.
Li HL; Zhang YJ; Chen XP; Luo JQ; Liu SY; Zhang ZL
Meta Gene; 2016 Sep; 9():18-25. PubMed ID: 27114919
[TBL] [Abstract][Full Text] [Related]
28. PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis.
Wang Q; Hao Y; Mo X; Wang L; Lu X; Huang J; Cao J; Li H; Gu D
Thromb Res; 2010 Dec; 126(6):498-503. PubMed ID: 20926117
[TBL] [Abstract][Full Text] [Related]
29. Association of Leu125Val polymorphisms in the PECAM-1 gene with the risk of coronary heartdisease: a meta-analysis.
Xia T; Liu X; Du CJ; Jin X; Kong XQ; Li G
Int J Clin Exp Med; 2015; 8(2):2219-25. PubMed ID: 25932154
[TBL] [Abstract][Full Text] [Related]
30. Significant association between functional microRNA polymorphisms and coronary heart disease susceptibility: a comprehensive meta-analysis involving 16484 subjects.
Liu X; You L; Zhou R; Zhang J
Oncotarget; 2017 Jan; 8(4):5692-5702. PubMed ID: 28035059
[TBL] [Abstract][Full Text] [Related]
31. Association between 5, 10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and congenital heart disease: A meta-analysis.
Wang W; Hou Z; Wang C; Wei C; Li Y; Jiang L
Meta Gene; 2013 Dec; 1():109-25. PubMed ID: 25606381
[TBL] [Abstract][Full Text] [Related]
32. Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls.
Li Y; Chen Z; Song H
Lipids Health Dis; 2018 Jan; 17(1):4. PubMed ID: 29304815
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.
Puppala J; Bhrugumalla S; Kumar A; Siddapuram SP; Viswa PD; Kondawar M; Akka J; Munshi A
Indian J Gastroenterol; 2014 Nov; 33(6):524-9. PubMed ID: 25319715
[TBL] [Abstract][Full Text] [Related]
34. E-selectin gene polymorphisms and essential hypertension in Asian population: an updated meta-analysis.
Cai G; Zhang B; Weng W; Shi G; Xue S; Song Y; Ma C
PLoS One; 2014; 9(7):e102058. PubMed ID: 25003340
[TBL] [Abstract][Full Text] [Related]
35. Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.
Pollex RL; Ban MR; Young TK; Bjerregaard P; Anand SS; Yusuf S; Zinman B; Harris SB; Hanley AJ; Connelly PW; Huff MW; Hegele RA
BMC Med Genet; 2007 Dec; 8():80. PubMed ID: 18096054
[TBL] [Abstract][Full Text] [Related]
36. Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.
van Hoek M; van Herpt TW; Dehghan A; Hofman A; Lieverse AG; van Duijn CM; Witteman JC; Sijbrands EJ
Diabetologia; 2011 Jun; 54(6):1360-7. PubMed ID: 21373834
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population.
Guettier JM; Georgopoulos A; Tsai MY; Radha V; Shanthirani S; Deepa R; Gross M; Rao G; Mohan V
J Clin Endocrinol Metab; 2005 Mar; 90(3):1705-11. PubMed ID: 15598690
[TBL] [Abstract][Full Text] [Related]
38. Association between apolipoprotein B XbaI polymorphisms and coronary heart disease: A meta-analysis.
Feng YY; Chen LY; Liu Y; Luo M; Yang TT; Hu YH; Chang J; Mao M
BMC Cardiovasc Disord; 2020 Jun; 20(1):265. PubMed ID: 32493216
[TBL] [Abstract][Full Text] [Related]
39. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
40. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
Fiegenbaum M; de Andrade FM; Hutz MH
Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
